Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription


1 Allergy
1 Allergy Asthma Proc
6 Ann Allergy Asthma Immunol
2 Chest
1 Clin Exp Allergy
1 Drugs
3 Eur Respir J
1 Int Arch Allergy Immunol
4 J Allergy Clin Immunol
4 J Asthma
3 N Engl J Med
3 Pediatr Pulmonol
2 PLoS One
1 Proc Natl Acad Sci U S A
3 Respir Med
4 Respir Res

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles


  1. CHANTVEERAWONG T, Sangkangjanavanich S, Chiewchalermsri C, Pradubpongsa P, et al
    Increased circulating CRTH2(+) Tregs are associated with asthma control and exacerbation.
    Allergy. 2021 Oct 22. doi: 10.1111/all.15145.
    PubMed         Abstract available

    Allergy Asthma Proc

  2. TASHKIN DP, Koltun A, Wallace R
    A generic fluticasone propionate and salmeterol dry powder inhaler: Evidence of usability, function, and robustness.
    Allergy Asthma Proc. 2021;42:30-35.
    PubMed         Abstract available

    Ann Allergy Asthma Immunol

  3. FINEMAN S, Lee G, Hernandez-Truillo V, Chipps BE, et al
    From the Pages of Allergy Watch.
    Ann Allergy Asthma Immunol. 2021 Jul 8. pii: S1081-1206(21)00490.

  4. BALL L, Velasquez SA, Jammal OMA, White AA, et al
    Atypical Eosinophilic Granulomatosis with Polyangiitis with Spontaneous Aspirin Reactivity and IgE Mediated Anaphylaxis.
    Ann Allergy Asthma Immunol. 2021 Jul 14. pii: S1081-1206(21)00502.

  5. GRANT T, Croce E, Matsui E
    Asthma and the Social Determinants of Health.
    Ann Allergy Asthma Immunol. 2021 Oct 18. pii: S1081-1206(21)01132.
    PubMed         Abstract available

    Asthma, in quest of optimizing care.
    Ann Allergy Asthma Immunol. 2021;127:517.

  7. CARR TF
    Treatment approaches for the patient with T2 low asthma.
    Ann Allergy Asthma Immunol. 2021;127:530-535.
    PubMed         Abstract available

  8. LAFORCE C, Chipps BE, Albers FC, Reilly L, et al
    Albuterol/budesonide for the treatment of exercise-induced bronchoconstriction in patients with asthma: the TYREE study.
    Ann Allergy Asthma Immunol. 2021 Oct 23. pii: S1081-1206(21)01169.
    PubMed         Abstract available


  9. SAFIRI S, Carson-Chahhoud K, Karamzad N, Sullman MJM, et al
    Prevalence, deaths and disability-adjusted-life-years (DALYs) due to asthma and its attributable risk factors in 204 countries and territories, 1990-2019.
    Chest. 2021 Oct 23. pii: S0012-3692(21)04206-9. doi: 10.1016/j.chest.2021.
    PubMed         Abstract available

  10. RUPANI H, Kent BD
    Using FeNO Measurement in Clinical Asthma Management.
    Chest. 2021 Oct 18. pii: S0012-3692(21)04109-X. doi: 10.1016/j.chest.2021.
    PubMed         Abstract available

    Clin Exp Allergy

  11. CAFFREY OSVALD E, Gong T, Lundholm C, Larsson H, et al
    Parental socioeconomic status and asthma in children - using a population-based cohort and family design.
    Clin Exp Allergy. 2021 Oct 22. doi: 10.1111/cea.14037.
    PubMed         Abstract available


  12. DOMINGO RIBAS C, Carrillo Diaz T, Blanco Aparicio M, Martinez Moragon E, et al
    Correction to: REal worlD Effectiveness and Safety of Mepolizumab in a Multicentric Spanish Cohort of Asthma Patients Stratified by Eosinophils: The REDES Study.
    Drugs. 2021 Oct 21. pii: 10.1007/s40265-021-01622.

    Eur Respir J

  13. PIJNENBURG MW, Frey U, De Jongste JC, Saglani S, et al
    Childhood asthma- pathogenesis and phenotypes.
    Eur Respir J. 2021 Oct 28. pii: 13993003.00731-2021.
    PubMed         Abstract available

  14. ELSEY L, Pantin T, Holmes LJ, Tavernier G, et al
    Outcomes over the first two years of treatment with mepolizumab in severe asthma.
    Eur Respir J. 2021 Oct 28. pii: 13993003.01313-2021.
    PubMed         Abstract available

  15. PORSBJERG C, Maitland-van der Zee AH, Brusselle G, Canonica GW, et al
    3TR: a pan-European cross-disease research consortium aimed at improving personalised biological treatment of asthma and COPD.
    Eur Respir J. 2021;58.

    Int Arch Allergy Immunol

  16. TORRE E, Sola D, Caramaschi A, Mignone F, et al
    A Pilot Study on Clinical Scores, Immune Cell Modulation, and Microbiota Composition in Allergic Patients with Rhinitis and Asthma Treated with a Probiotic Preparation.
    Int Arch Allergy Immunol. 2021 Oct 21:1-15. doi: 10.1159/000518952.
    PubMed         Abstract available

    J Allergy Clin Immunol

  17. REDMOND C, Akinoso-Imran AQ, Heaney LG, Sheikh A, et al
    Socioeconomic disparities in asthma healthcare utilization, exacerbations and mortality: A systematic review and meta-analysis.
    J Allergy Clin Immunol. 2021 Oct 18. pii: S0091-6749(21)01560.
    PubMed         Abstract available

  18. TJALVIN G, Svanes O, Igland J, Bertelsen RJ, et al
    Maternal preconception occupational exposure to cleaning products and disinfectants and offspring asthma.
    J Allergy Clin Immunol. 2021 Oct 11. pii: S0091-6749(21)01399.
    PubMed         Abstract available

  19. PINKERTON JW, Kim RY, Brown AC, Rae BE, et al
    Relationship between type 2 cytokine and inflammasome responses in obesity-associated asthma.
    J Allergy Clin Immunol. 2021 Oct 19. pii: S0091-6749(21)01525.
    PubMed         Abstract available

  20. SKEVAKI C, Ngocho JS, Amour C, Schmid-Grendelmeier P, et al
    Epidemiology and management of asthma and atopic dermatitis in sub-Saharan Africa.
    J Allergy Clin Immunol. 2021 Oct 26. pii: S0091-6749(21)01631.
    PubMed         Abstract available

    J Asthma

  21. VAN DEN BOSCH WB, Kloosterman SF, Andrinopoulou ER, Greidanus R, et al
    Small airways targeted treatment with smart nebulizer technology could improve severe asthma in children: a retrospective analysis.
    J Asthma. 2021 Oct 26:1-13. doi: 10.1080/02770903.2021.1996597.
    PubMed         Abstract available

  22. MOSNAIM GS, Stempel DA, Gonzalez C, Adams B, et al
    Electronic Medication Monitoring vs. Self-Reported Use of Inhaled Corticosteroids and Short-Acting Beta2-Agonists in Uncontrolled Asthma.
    J Asthma. 2021 Oct 26:1-6. doi: 10.1080/02770903.2021.1996600.
    PubMed         Abstract available

  23. ERTURK G, Gunday C, Evrendilek H, Sagir K, et al
    Effects of High Intensity Interval Training and Sprint Interval Training in Patients with Asthma: A Systematic Review.
    J Asthma. 2021 Oct 27:1-19. doi: 10.1080/02770903.2021.1999470.
    PubMed         Abstract available

  24. BRITTAN MS, Moss A, Watson JD, Federico MJ, et al
    Association between early childhood lower respiratory tract infections and subsequent asthma.
    J Asthma. 2021 Oct 27:1-16. doi: 10.1080/02770903.2021.1999469.
    PubMed         Abstract available

    N Engl J Med

  25. BARDIN PG, Foster PS
    Clinical Translation of Basic Science in Asthma.
    N Engl J Med. 2021;385:1714-1717.

  26. BRIGHTLING CE, Nair P, Cousins DJ, Louis R, et al
    Risankizumab in Severe Asthma - A Phase 2a, Placebo-Controlled Trial.
    N Engl J Med. 2021;385:1669-1679.
    PubMed         Abstract available

  27. WECHSLER ME, Ruddy MK, Pavord ID, Israel E, et al
    Efficacy and Safety of Itepekimab in Patients with Moderate-to-Severe Asthma.
    N Engl J Med. 2021;385:1656-1668.
    PubMed         Abstract available

    Pediatr Pulmonol

  28. ROSS MK, Friedman S, Radparvar I, Ryan G, et al
    Partnered decision support: Parental perspectives of completing a pre-visit pediatric asthma questionnaire via the patient portal.
    Pediatr Pulmonol. 2021 Oct 21. doi: 10.1002/ppul.25735.
    PubMed         Abstract available

  29. YANG Z, Wang X, Wan XG, Wang ML, et al
    Pediatric asthma control during the COVID-19 pandemic: a systematic review and meta-analysis.
    Pediatr Pulmonol. 2021 Oct 21. doi: 10.1002/ppul.25736.
    PubMed         Abstract available

  30. RIZZARDI KF, Toledo EDS, Ferraz LFC, Darrieux M, et al
    Association between asthma and enamel defects in primary and young permanent teeth - a systematic review.
    Pediatr Pulmonol. 2021 Oct 26. doi: 10.1002/ppul.25737.
    PubMed         Abstract available

    PLoS One

  31. ABDUR REHMAN N, Counts S
    Neighborhood level chronic respiratory disease prevalence estimation using search query data.
    PLoS One. 2021;16:e0252383.
    PubMed         Abstract available

  32. LEE J, Lee SH, Gu GJ, Choi JH, et al
    Alterations of lung microbial communities in obese allergic asthma and metabolic potential.
    PLoS One. 2021;16:e0256848.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  33. DUTTA J, Rehman R, Vellarikkal SK, Fredenburgh LE, et al
    Possible selection bias limits the interpretation of single-cell transcriptomics data of steroid-resistant asthma exacerbation.
    Proc Natl Acad Sci U S A. 2021;118.

    Respir Med

  34. BJERRUM AS, Skjold T, Schmid JM
    Oral corticosteroid sparing effects of anti-IL5/ anti-IL5 receptor treatment after 2 years of treatment.
    Respir Med. 2021;176:106260.
    PubMed         Abstract available

  35. TIOTIU A, Ioan I, Poussel M, Schweitzer C, et al
    Comparative analysis between available challenge tests in the hyperventilation syndrome.
    Respir Med. 2021;179:106329.
    PubMed         Abstract available

  36. ZELL-BARAN LM, Krefft SD, Moore CM, Wolff J, et al
    Multiple breath washout: A noninvasive tool for identifying lung disease in symptomatic military deployers.
    Respir Med. 2021;176:106281.
    PubMed         Abstract available

    Respir Res

  37. HARDING JN, Gross M, Patel V, Potter S, et al
    Association between particulate matter containing EPFRs and neutrophilic asthma through AhR and Th17.
    Respir Res. 2021;22:275.
    PubMed         Abstract available

  38. TUPPER OD, Ulrik CS
    Long-term predictors of severe exacerbations and mortality in a cohort of well-characterised adults with asthma.
    Respir Res. 2021;22:269.
    PubMed         Abstract available

  39. VAN DEN BERG MPM, Nijboer-Brinksma S, Bos IST, van den Berge M, et al
    The novel TRPA1 antagonist BI01305834 inhibits ovalbumin-induced bronchoconstriction in guinea pigs.
    Respir Res. 2021;22:48.
    PubMed         Abstract available

  40. WANG Y, Liao K, Liu B, Niu C, et al
    GITRL on dendritic cells aggravates house dust mite-induced airway inflammation and airway hyperresponsiveness by modulating CD4(+) T cell differentiation.
    Respir Res. 2021;22:46.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Asthma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.